Clincosm LogoSign in Get a demo

Depressive Disorder, Treatment-Resistant

Showing 26 - 42 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant Trial in Saint Louis (Nitrous Oxide, Placebo gas, MRI)

Terminated
  • Depressive Disorder, Major
  • Depressive Disorder, Treatment-Resistant
  • Nitrous Oxide
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 29, 2021

Old Age, Depressive Disorder, Treatment-Resistant Trial in Jette (a Magstim Rapid2 Plus1 Magnetic Stimulator connected to a

Recruiting
  • Old Age
  • Depressive Disorder, Treatment-Resistant
  • a Magstim Rapid2 Plus1 Magnetic Stimulator connected to a Brainsway H1 coil
  • Jette, Brussels, Belgium
    UZ Brussel
Apr 27, 2021

Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant Trial in United States (REL-1017, Placebo)

Completed
Has Results
  • Depressive Disorder, Major
  • Depressive Disorder, Treatment-Resistant
  • Little Rock, Arkansas
  • +9 more
Mar 16, 2021

Depressive Disorder, Treatment-Resistant Trial in London (Quetiapine, Lithium)

Recruiting
  • Depressive Disorder, Treatment-Resistant
  • London, United Kingdom
    Institute of Psychiatry, Psychology and Neuroscience, King's Col
Mar 3, 2021

Depressive Disorder, Treatment-Resistant Trial in Orangeburg (Ketamine Hydrochloride)

Completed
  • Depressive Disorder, Treatment-Resistant
  • Ketamine Hydrochloride
  • Orangeburg, New York
    Nathan Kline Institute
Jan 20, 2021

Depressive Disorder, Treatment-Resistant Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))

Completed
Has Results
  • Depressive Disorder, Treatment-Resistant
  • Birmingham, Alabama
  • +159 more
May 21, 2020

Depressive Disorder, Treatment-Resistant Trial (Esketamine)

Approved for marketing
  • Depressive Disorder, Treatment-Resistant
  • (no location specified)
Feb 6, 2020

Depressive Disorder, Treatment-Resistant Trial (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)

Withdrawn
  • Depressive Disorder, Treatment-Resistant
  • Esketamine 28 mg
  • +10 more
  • (no location specified)
Nov 22, 2019

Treatment Resistant Depression, Depressive Disorder, Treatment-Resistant, Depression, Bipolar Trial in Lebanon (SCC DBS)

Completed
Has Results
  • Treatment Resistant Depression
  • +2 more
  • SCC DBS
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Jul 10, 2019

Depressive Disorder, Treatment-Resistant, Stress Disorders, Post-Traumatic Trial in Minneapolis (Ketamine)

Completed
  • Depressive Disorder, Treatment-Resistant
  • Stress Disorders, Post-Traumatic
  • Minneapolis, Minnesota
    Minneapolis Va Health Care System, Minneapolis MN
May 10, 2019

Depressive Disorder, Treatment-Resistant Trial in Calgary (deep brain stimulation with short & long pulse width)

Completed
  • Depressive Disorder, Treatment-Resistant
  • deep brain stimulation with short & long pulse width
  • Calgary, Alberta, Canada
    University of Calgary & Alberta Health Services, Foothills Medic
Apr 16, 2019

Resistant Depression in the United States (US)

Completed
  • Depressive Disorder, Treatment-Resistant
    • (no location specified)
    Mar 8, 2019

    Depressive Disorder, Treatment-Resistant Trial in Calgary (Theta Burst Stimulation ( Transcranial Magnetic Stimulation))

    Unknown status
    • Depressive Disorder, Treatment-Resistant
    • Theta Burst Stimulation ( Transcranial Magnetic Stimulation)
    • Calgary, Alberta, Canada
      University of Calgary
    Aug 7, 2018

    Depression, Depressive Disorder, Depressive Disorder, Treatment-resistant Trial in United States (LFMS)

    Completed
    Has Results
    • Depression
    • +3 more
    • LFMS
    • Garden Grove, California
    • +11 more
    Oct 31, 2017

    Depressive Disorder, Treatment-Resistant Trial in United States (AVP-786 (d6-dextromethorphan hydrobromide and quinidine sulfate

    Completed
    • Depressive Disorder, Treatment-Resistant
    • AVP-786 (d6-dextromethorphan hydrobromide and quinidine sulfate combination)
    • Placebo
    • Birmingham, Alabama
    • +31 more
    May 11, 2017

    Depressive Disorder, Treatment-Resistant Trial in Mexico City (Ketamine)

    Unknown status
    • Depressive Disorder, Treatment-Resistant
    • Mexico City, Distrito Federal, Mexico
      National Institute of Neurology and Neurosurgery
    Sep 20, 2016

    Epidemiology of Treatment Resistant Depression in Taiwan

    Completed
    • Depressive Disorder, Treatment-Resistant
      • (no location specified)
      Mar 22, 2016